Status:
COMPLETED
Oseltamivir Randomised Controlled Efficacy Trial
Lead Sponsor:
International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Influenza
Pneumonia
Eligibility:
All Genders
1+ years
Phase:
PHASE3
Brief Summary
Background In preparation for a global influenza pandemic, there is an urgent need for representative data from populations and settings where the pandemic is most likely to arise. There are no data o...
Detailed Description
Purpose Influenza is a disease of global importance, having caused three pandemics in the 20th Century. Although concerns persist about a new pandemic, possibly from an avian influenza A strain, more ...
Eligibility Criteria
Inclusion
- Persons at least one year old residing in randomly selected households with at least one major illness sign, or if absent at least two minor illness signs who are rapid test positive for either influenza A or influenza B.
Exclusion
- Persons with a history of non-febrile convulsions or
- Persons who are taking anticonvulsive agents, or
- Persons who have a nonrespiratory comorbid condition requiring immediate medical intervention, or
- Persons who are pregnant.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
1190 Patients enrolled
Trial Details
Trial ID
NCT00707941
Start Date
May 1 2008
End Date
March 1 2011
Last Update
June 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kamalapur Urban Site, ICDDR,B
Dhaka, Bangladesh, 1000